COMMUNIQUÉS West-GlobeNewswire

Ligand to Host Investor Day on December 8, 2026
22/10/2026
JUPITER, Fla., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its annual Investor Day will take place on Tuesday, December 8, 2026 from 10:30 a.m. to 12:00 p.m [...]
Health Catalyst to Announce Third Quarter 2026 Operating Results and Host Conference Call on Thursday, November 5, 2026
22/10/2026
SALT LAKE CITY, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release [...]
Telitacicept Demonstrates Durable Preservation of Kidney Function Through Two Years in Phase 3 TELIGAN Trial in IgA Nephropathy
22/10/2026
Annualized eGFR slope of -0.6 vs. -5.7 mL/min/1.73 m²/year for placebo, a 5.1 mL/min/1.73 m²/year treatment difference (p<0.001) 89% and 81% reductions in risk of confirmed ≥30% and ≥40% eGFR declines, respectively [...]
Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data
22/10/2026
Clinical development of ARD-101 for hyperphagia in Prader-Willi Syndrome (PWS) may resume Aardvark will host a webcast to review available dataset from the terminated Phase 3 HERO trial and OLE trial on Friday, October [...]
Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development
22/10/2026
Collaboration aims to improve trial planning and expand patient access to biomarker-matched studies in Australia Highlights Collaboration aims to accelerate precision oncology research in Australia Combines Fortrea’s [...]
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
22/10/2026
WALTHAM, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
Elutia to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026
22/10/2026
GAITHERSBURG, Md., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its third quarter 2026 [...]
Emmy-Award Winning Television Host Montel Williams to Join Next ‘Let’s Huddle’ Webinar
22/10/2026
Patient advocacy initiative expands its reach with a nationally recognized voice on health, resilience and informed treatment decisions TORONTO, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX [...]
VisCardia Announces Publication of RECOVER-HF Pilot Trial in JACC: Heart Failure
22/10/2026
Publication marks a milestone for VisONE™ cardiac diaphragm support as enrollment continues in the RECOVER-HF pivotal IDE trial PORTLAND, Ore., Oct. 22, 2026 (GLOBE NEWSWIRE) -- VisCardia, Inc. today announced the [...]
CORRECTION -- Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
22/10/2026
Clears Pathway for Execution of Future R&D Milestone Events such as the Phase 1b, FIH Study for PRP in up to 50 Advanced Cancer Patients with Solid Tumors, First Quarter, 2027 MELBOURNE, Australia, Oct. 22, 2026 ( [...]
FocalTherics™ to Announce Third Quarter 2026 Financial Results on November 5, 2026
22/10/2026
Company to host conference call and webcast on Thursday, November 5 at 4:30 p.m. ET FocalTherics ™ to Announce Third Quarter 2026 Financial Results on November 5, 2026 Company to host conference call and webcast on [...]
CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026
22/10/2026
MINNEAPOLIS, Oct. 22, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Park Family & Cosmetic Dentistry Named Best Cosmetic Dentistry Practice in Naples, FL
22/10/2026
The locally owned cosmetic and family dental practice won the Cosmetic Dentistry category of the 2026 Naples Community's Choice Awards for the second consecutive year, selected by votes from the Naples community. Naples [...]
Delta Dental Foundation of North Carolina Commits $1 Million to Expand Oral Health Access Statewide
22/10/2026
Investments target children's and adult oral health and growing the workforce that makes access and dental care possible Raleigh, North Carolina, Oct. 22, 2026 (GLOBE NEWSWIRE) -- The Delta Dental Foundation of North [...]
Enlivex Announces 1-for-16 Reverse Share Split to be Effective October 27, 2026
22/10/2026
Nes-Ziona, Israel, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) ("Enlivex" or the "Company"), a quality longevity company powered by a prediction markets treasury, today announced a 1-for-16 reverse [...]
Immuron CEO, Steven Lydeamore presentation at Emerging Growth Conference
23/10/2026
MELBOURNE, Australia, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief Executive Officer, Steven Lydeamore is presenting virtually at the Emerging Growth [...]
Mineralys Therapeutics Presents New Lorundrostat Data in Participants with Hypertension and Chronic Kidney Disease at ASN Kidney Week 2026
23/10/2026
In the large, pivotal Phase 3 Launch-HTN trial, lorundrostat achieved similar significant blood pressure reductions in participants with and without CKD, with consistent reductions across Stages 1-3 CKD In participants [...]
Le KFSH renforce ses capacités de prise en charge des soins complexes en repensant le parcours des patients aux urgences
23/10/2026
RIYADH, Arabie saoudite, 23 oct. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH) a renforcé sa capacité de prise en charge des soins complexes en repensant le parcours des patients [...]
Lycia Therapeutics Announces Pricing of Upsized Initial Public Offering
23/10/2026
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc. (“Lycia”) (Nasdaq: LYCA), a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics [...]

Pages